Logo

Nuvelo Issues Public Stock Offering Valued at $65M

Mar 03, 2004

NEW YORK, March 3 (GenomeWeb News) - Nuvelo is offering 5 million shares of its common stock at a price of $13.00 per share, the company said today.

The total value of the public offering is $65 million.

The company increased the size of the offering from 4 million shares, which it announced in February.

The underwriters of the offering have the option to purchase up to an additional 750,000 shares to cover over-allotments, the company said. UBS Securities is the sole book-running manager in the offering, while CIBC World Markets, Needham & Company, and JMP Securities are co-managers.

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.